QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data

Shares of uniQure (QURE) collapsed 37% on Tuesday after four-year results from its Huntington’s gene therapy study missed a key statistical test, even as the company said the treatment still slowed decline, and analysts largely kept bullish ratings.Shares clocked their worst day since Nov. 2025 and…